The real challenge of non-clinical/technical authoring is integrating and harmonizing diverse non-clinical PK, PD and toxicology findings within evolving guidelines while maintaining scientific rigor, precision and clarity.
We can assist you with the following:
We author and update the non-clinical sections of Investigator’s Brochures, presenting your pharmacology, pharmacokinetics, and toxicology data in a clear, concise, and compliant manner to support clinical trial applications and ongoing development.
Our experts prepare non-clinical content for global regulatory submissions, including CTD Modules 2.4, 2.6, and 4. We ensure that your data is presented in a scientific, compliant, and compelling format to support successful CTAs, INDs, IMPDs, NDAs, BLAs, and MAAs.
We develop submission-ready non-clinical study reports, including toxicology, pharmacology, ADME, and safety pharmacology studies. Our reports meet GLP standards and are written to align with current regulatory expectations.
We specialize in drafting company positions and non-clinical justifications for regulatory interactions including scientific advice/formal meeting procedures, briefing books, and responses to agency questions. Please visit Agency Interactions for more information.
We specialize in the authoring of Safety and Toxicological Risk Assessments, a crucial step in ensuring the safe development of your drug. Our team thoroughly evaluates potential hazards based on comprehensive toxicological data. These assessments provide a clear understanding of risks and inform critical development decisions ensuring compliance with ICH, EMA and FDA requirements. Please visit Toxicological Risk Assessment for more information.
We offer detailed scientific reviews and quality control checks to ensure that non-clinical documents are accurate, well-structured, and aligned with the regulatory requirements.
To streamline collaboration and ensure consistency across your non-clinical documentation, we provide tailored non-clinical templates, style guides, and authoring frameworks designed around your program’s needs.
Contact us today to discuss how our tailored approach can support your regulatory requirements and advance your research objectives. Together, let’s shape the future of safer and more effective therapies.
Clear, Compliant Documentation for Global Submissions
Our expertise
We provide specialized non-clinical regulatory writing services to support the development and registration of pharmaceuticals, biologics, advanced therapy medicinal products (ATMPs), RNA therapeutics, nanomedicines, vaccines, medical devices and combination products. Our experienced medical and regulatory writers deliver high-quality non-clinical documentation that consistently meets global regulatory requirements, including ICH, FDA, EMA, and MHRA guidelines.
Partner with Starodub’s regulatory experts today to leverage our expert writing services, streamline your regulatory submissions and accelerate your path to clinical development and marketing authorization.
Approach & Expertise
Learn how we can support you in meeting your business goals
- Our lean and powerful team with degrees in pharmacy, chemistry, biology, or related studies strive to be of added value to you. Our short reporting lines enable the most efficient road to your success.
- Having one point of contact from our experts backed by the team’s collective knowledge and resources we give reliable advice and execute projects seamlessly.
- At Starodub, consistency and assurance of quality are vital. A quality management system has been implemented and we adhere to GxP and ISO 9001/13485.
Questions from our clients
FAQ Section
Expert non-clinical authoring involves the integration and interpretation of complex pharmacology, pharmacokinetics and toxicology data across multiple study types. It also requires a deep understanding of regulatory guidelines (ICH, EMA, FDA, MHRA, others) and the ability to extract meaningful conclusions−such as NOAELs, dose-response relationships, safety margins, and species relevance−for inclusion in CTD Modules 2.4, 2.6 and 4. Our expert team ensures that each document presents a scientifically sound and strategically aligned narrative to support successful regulatory decisions and product development. We collaborate closely with CMC/Quality, Clinical, and Regulatory teams to ensure consistency in data interpretation and decision-making across disciplines.